Apreohealth
Apreo Health is a clinical-stage medical device company based in Menlo Park, California, developing a novel, tissue-sparing bronchoscopic treatment for severe emphysema. Its investigational Apreo BREATHE Airway Scaffold uses a self-expanding nitinol scaffold to tent open targeted airways, releasing trapped air and reducing lung hyperinflation without removing healthy tissue. The device received FDA Breakthrough Device Designation in 2024 and is being evaluated in the BREATHE clinical trial program. Backed by Norwest Venture Partners, F-Prime Capital, and OSF Ventures, Apreo Health is a physical medical device company with no public developer API, SDK, or software platform; this profile tracks the company as a portfolio lead in the API Evangelist network.
Apreohealth is profiled on the APIs.io network. Tagged areas include Company, Medical Devices, Healthcare, Respiratory, and Emphysema.
Kin Score
Security Posture 1
Authentication, domain security, vulnerability disclosure, and trust-center signals.
Resources
Access & Security 1
Authentication, authorization, and security posture
Commercial 1
Pricing, plans, and the legal terms of use
Company 1
The organization behind the API